FDA InspectionJoseph L. Lillo, D.O.
Joseph L. Lillo, D.O. – FDA Inspection, Mar 22, 2021
Record Details
This FDA Inspection record concerns Joseph L. Lillo, D.O., with an inspection on March 22, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Joseph L. Lillo, D.O.
- Inspection Date
- March 22, 2021
- Product Type
- Drugs
ID · 5a802237-2c7a-4b96-a384-8d98800b915f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1136939
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Joseph L. Lillo, D.O.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 17, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 12, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 26, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Joseph L. Lillo, D.O. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA